Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Alpha-1 adrenergic blocker that is used on benign prostatic hypertrophy and other problems like voiding difficulty and obstruction including those caused by lithiasis.
At latest update relevant published data on its excretion into breast milk were not found.
Because of a high protein-binding capacity it is unlikely an excretion into breastmilk in significant amounts.
Use not indicated on women. Several studies have reported usefulness for the removal of urinary stones. There is no evidence of efficacy in the prevention of post-traumatic urinary retention.
Since it may cause hypotension in the infant, until more data on this drug is available, a safer and known alternative may be preferable, especially in cases of nursing infants younger than one month of age and premature babies.